Ganoderma lucidum polysaccharides in human monocytic leukemia cells: from gene expression to network construction
2007

Effects of Ganoderma lucidum Polysaccharides on Human Leukemia Cells

publication Evidence: moderate

Author Information

Author(s): Cheng Kun-Chieh, Huang Hsuan-Cheng, Chen Jenn-Han, Hsu Jia-Wei, Cheng Hsu-Chieh, Ou Chern-Han, Yang Wen-Bin, Chen Shui-Tein, Wong Chi-Huey, Juan Hsueh-Fen

Primary Institution: National Taiwan University

Hypothesis

How does the polysaccharide F3 from Ganoderma lucidum stimulate immuno-modulating or anti-tumor effects in human leukemia THP-1 cells?

Conclusion

F3 may induce death receptor ligands to initiate signaling that leads to apoptosis in THP-1 cells.

Supporting Evidence

  • F3 was found to activate various cytokines such as IL-1, IL-6, IL-12, and TNF-α.
  • The apoptosis induction through the DR3 and DR4/5 death receptors was identified as a significant pathway.
  • F3 treatment led to significant changes in gene expression profiles in THP-1 cells.

Takeaway

This study shows that a substance from a mushroom can help kill cancer cells by making them die in a specific way.

Methodology

The study used DNA microarray analysis, quantitative PCR assays, and bioinformatics methods to analyze gene expression in THP-1 cells treated with F3.

Statistical Information

P-Value

0.0044

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2164-8-411

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication